![]() |
市場調查報告書
商品編碼
1897309
獸醫免疫診斷市場規模、佔有率和成長分析(按產品類型、技術、動物種類、疾病種類、最終用戶和地區分類)-2026-2033年產業預測Veterinary Immunodiagnostics Market Size, Share, and Growth Analysis, By Product, By Technology, By Animal Type, By Disease Type, By End User, By Region - Industry Forecast 2026-2033 |
||||||
全球獸醫免疫診斷市場規模預計在 2024 年達到 29.2 億美元,從 2025 年的 31.6 億美元成長到 2033 年的 58.9 億美元,在預測期(2026-2033 年)內複合年成長率為 8.1%。
全球獸醫免疫診斷市場預計將因動物疾病的日益增加、專業免疫診斷檢測的普及以及技術的進步而成長。寵物飼養量的快速成長和對動物性食品需求的不斷增加也進一步推動了市場擴張。新興經濟體蘊藏著巨大的成長潛力,但由於這些地區獸醫診斷基礎設施的匱乏,也面臨許多挑戰。此外,全球疫情引發的檢測需求激增,促使業界相關人員和實驗室開發新的動物檢測解決方案。儘管主要衛生組織不建議對動物進行常規的新冠病毒檢測,但隨著公共衛生情況的變化,是否進行檢測的決定可能會隨之而來,並可能需要獸醫和衛生部門的共同決策。
推動全球獸醫免疫診斷市場發展的因素
全球獸醫免疫診斷市場的主要驅動力是應對通用病的迫切需求,這些感染疾病可從動物傳播給人類。由於許多病原體來自家畜和通用動物(如犬貓),因此疾病傳播的可能性很高。狂犬病、鉤端螺旋體病和胃腸道疾病等主要感染疾病凸顯了獸醫學領域對有效診斷解決方案的需求。隨著人們對這些健康風險的認知不斷提高,對先進免疫診斷工具的需求日益迫切,以確保公眾和動物健康,最終推動獸醫診斷市場的成長和創新。
全球獸醫免疫診斷市場阻礙因素
寵物照護成本的不斷上漲是全球獸醫免疫診斷市場發展面臨的一大阻礙因素。獸醫醫療費用已成為寵物護理行業最大的支出項目之一,給寵物飼主帶來了沉重的財務負擔。先進診療計畫的價格漲幅驚人,往往高達數千至數萬美元。此外,即使是常規的獸醫服務也可能需要花費數百至數千美元。這些日益成長的經濟壓力可能會阻礙寵物飼主獲得必要的診斷服務,最終影響該市場的整體需求。
全球獸醫免疫診斷市場趨勢
受環境變化和社會經濟因素的影響,感染疾病和媒介傳播疾病的發生率不斷上升,推動了全球獸醫免疫診斷市場顯著成長。已開發地區寵物主人數量的增加以及伴侶動物照護日益受到重視,促使市場對快速、準確的診斷工具的需求激增。此外,RT-PCR等先進技術的日益普及也進一步強化了這一趨勢,這些技術比傳統方法更有效率、更準確。有效疾病控制策略的需求凸顯了獸醫免疫診斷的關鍵作用,預計該市場將持續成長,以應對不斷變化的動物健康挑戰。
Global Veterinary Immunodiagnostics Market size was valued at USD 2.92 Billion in 2024 and is poised to grow from USD 3.16 Billion in 2025 to USD 5.89 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).
The global veterinary immunodiagnostics market is poised for growth driven by the increasing prevalence of animal diseases, enhanced access to specialized immunodiagnostic tests, and advancements in technology. The surge in pet ownership and demand for animal-derived food products further bolster market expansion. Emerging economies present promising opportunities for growth; however, the market faces challenges stemming from inadequate veterinary diagnostic infrastructure in these regions. Additionally, the heightened focus on testing due to the global pandemic has spurred the development of novel animal testing solutions by industry players and laboratories. While major health organizations do not endorse routine COVID-19 testing in animals, decisions regarding testing may arise from evolving public health circumstances, necessitating collective judgments by veterinarians and health officials.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Immunodiagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Veterinary Immunodiagnostics Market Segments Analysis
Global Veterinary Immunodiagnostics Market is segmented by Product, Technology, Animal Type, Disease Type, End User and region. Based on Product, the market is segmented into Consumables and Instruments. Based on Technology, the market is segmented into Clinical Biochemistry, Molecular Diagnostics, Hematology, Urinalysis, Immunodiagnostics and Other Veterinary Diagnostic Technologies. Based on Animal Type, the market is segmented into Companion Animals and Livestock. Based on Disease Type, the market is segmented into Infectious Disease, Endocrinology, Oncology, Cardiology and Others. Based on End User, the market is segmented into Veterinary Reference Laboratories, Veterinary Hospitals & Clinics, Point-of-care/ In-house Testing and Veterinary Research Institutes & Universities. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Veterinary Immunodiagnostics Market
The Global Veterinary Immunodiagnostics market is significantly driven by the pressing need to address serious zoonotic illnesses that can be transmitted from animals to humans. With numerous pathogens originating from livestock and companion animals, such as dogs and cats, the potential for disease transmission is high. Notable zoonotic infections, including rabies, leptospirosis, and gastrointestinal diseases, highlight the necessity for effective diagnostic solutions in veterinary medicine. As awareness of these health risks grows, the demand for advanced immunodiagnostic tools becomes increasingly vital to ensure public and animal health, ultimately propelling market growth and innovation in veterinary diagnostics.
Restraints in the Global Veterinary Immunodiagnostics Market
The rising expenses associated with pet care are a notable restraint in the Global Veterinary Immunodiagnostics market. Veterinary care has become one of the largest cost categories within the pet care industry, reflecting a significant financial burden for pet owners. The increasing prices of high-end procedures can be staggering, often ranging from thousands to tens of thousands of dollars. Additionally, even routine veterinary services can lead to considerable expenditures, ranging from a few hundred to several thousand dollars. This growing financial pressure may deter pet owners from seeking necessary diagnostic services, ultimately impacting the overall demand in this market.
Market Trends of the Global Veterinary Immunodiagnostics Market
The Global Veterinary Immunodiagnostics market is witnessing significant growth driven by the increasing prevalence of zoonotic and vector-borne diseases, influenced by environmental changes and socio-economic factors. As pet ownership rises and companion animal healthcare gains prominence in developed regions, the demand for rapid and precise diagnostic tools intensifies. This trend is further bolstered by a heightened preference for advanced technologies such as RT-PCR, surpassing traditional methods in both efficiency and accuracy. The need for effective disease management strategies highlights the pivotal role of veterinary immunodiagnostics, positioning the market for sustained expansion in response to evolving health challenges in animals.